Log in
Log in


<< First  < Prev   1   2   3   Next >  Last >> 
  • Tue, January 16, 2024 4:05 AM | Karen Gottlieb (Administrator)

    Kenneth E. Moore, 90, died Jan. 9, 2024, at his home in Ogden, Utah.

    Ken was a pioneer in the field of pharmacology and was one of the first professors in the Department of Pharmacology and Toxicology at Michigan State University, which he chaired for 14 years. His groundbreaking neuropsychopharmacology research was supported continuously from 1962-2000 by grants from the National Institutes of Health and won him numerous awards, accolades and invitations to speak. He authored or co-authored 277 original research articles, 42 book chapters or review articles and one of the first psychopharmacology textbooks, “Introduction to Psychopharmacology” in 1971. He enjoyed mentoring many undergraduate and graduate students and young scientists.

    Ken was born in Edmonton, Alberta, to Jack Moore and Emily “Ivy” (Tarbox) Moore. As a young man, he enjoyed the outdoors and he passed on his love of music, camping, hiking and skiing to his children.

    Ken was a running back for the Edmonton Wildcats and played in the 1952 Canadian Junior Football Championship game. He obtained his bachelor’s and master’s degrees in pharmacy from the University of Alberta and his PhD in pharmacology from the University of Michigan. Ken began his academic career as an associate professor in the medical school at Dartmouth College before joining the faculty at MSU in 1966. In 1974, he spent a year as a visiting scholar at Cambridge University in Cambridge, England.

    Ken was a devoted sports fan, having held season tickets to MSU football and hockey games for many years. Topping his list of favorite teams were the Detroit Lions and Detroit Red Wings. He enjoyed playing squash and served as a referee for youth hockey. But his favorite game was golf, and he enjoyed many rounds at the Forest Akers golf course in East Lansing. In 2014, he made the generous gift of a stone bridge over a water hazard on the 18th hole of the West Course to be used by walking golfers like himself.

    He was married for 70 years to Barry Moore and together they traveled the world and shared many adventures. Always prepared with a quick one-liner, often to the chagrin of his children, Ken was outgoing and loved to meet people and had friends around the globe. Ken and Barry moved to Ogden, Utah, in 2019 to be near family. There, he was able to continue his love of gardening and bird watching as he settled into old age.

    Ken is survived by his wife, Barry; son, Grant Moore; daughter Sandi Booth and her husband, Stan; daughter Lynn Moore and her partner Greg DeRuiter; grandchildren Shane Moore, Matthew Moore, Helena Gryzenia, Ashley Booth Morton and Hana Garcia as well as Daniel DeRuiter and David DeRuiter; and five great grandchildren.

    He was preceded in death by his parents, brother Dennis Moore, sister Ivy May Flarup and son-in-law George Gryzenia.

    No service will be held, and the family suggests that those wishing to honor Ken’s memory make a donation to the Moore Distinguished Alumnus Lectureship fund at Michigan State University via or to Planned Parenthood.

    View Kenneth E. Moore's obituary

  • Wed, August 02, 2023 5:05 PM | Karen Gottlieb (Administrator)

    portrait of dr. corson in the lab

    INDIANAPOLIS—Indiana University School of Medicine has named Timothy W. Corson, PhD, as the new chair of the Department of Pharmacology and Toxicology.

    Corson is currently the Merrill Grayson Senior Professor in Ophthalmology and Vice Chair for Basic and Translational Research in the Department of Ophthalmology at IU School of Medicine. He also holds appointments in the Department of Pharmacology and Toxicology and in the Department of Biochemistry and Molecular Biology.

    Since joining IU School of Medicine in 2010, Corson has demonstrated world-class research in his laboratory, and a devotion to mentorship through his work with students—ranging in age from high school, undergraduate, medical students and residents, as well as faculty. He directs the Basic Science Research in Ophthalmology elective for upper-year medical students, and also has co-led summer research programs at the IU Melvin and Bren Simon Comprehensive Cancer Center for high school and undergraduate students from populations underrepresented in medicine.

    “Dr. Corson is a collaborative and transformational leader, well-funded researcher and dedicated educator,” said Jay L. Hess, MD, PhD, MHSA, dean of IU School of Medicine and Executive Vice President of University Clinical Affairs for IU. “His vision aligns with the School of Medicine’s interdisciplinary and aspirational approach to education and research. I’m confident he will advance us to further excellence across all of our missions.”

    The major focus of Corson’s lab at IU is neovascular eye diseases. Through his work, he has identified two novel protein targets for blocking neovascularization in eye diseases like wet age-related macular degeneration and has discovered novel lead therapeutic compounds covered by multiple patent applications. His research program has resulted in more than 80 papers and 11 patents during his career and has been supported by more than $7.2 million in grant funding.

    For the past five years, Corson has served as the leader of laboratory research in the Department of Ophthalmology. In this role he has helped lead the department in recruiting top new talent and mentoring existing faculty—with support of chair David Wallace, MD, MPH, this has more than quadrupled the department’s NIH funding between 2019 and 2021.

    “I am honored by the opportunity to lead the Department of Pharmacology and Toxicology and am excited to take on this new challenge,” said Corson. “Pharmacology and toxicology is a unique field given its central role in all aspects of medicine. The outstanding faculty with the department reflect the major strategic areas of IU School of Medicine research. I’m eager to work with the faculty to continue to forge new collaborations to advance our leading-edge research and education here at the school.”

    Corson is a 1999 graduate of the University of Toronto with an Honors Bachelor of Science (HonBSc) in molecular genetics and molecular biology. He earned his Master of Science (MSc) in neuroscience/pharmacology and a PhD in molecular genetics, also from the University of Toronto, and later pursued chemical biology research as the Canadian Institutes of Health Research Jean-François St-Denis Fellow in Cancer Research at Yale University.

    Corson will officially assume his new role April 1, 2023.

  • Thu, July 27, 2023 2:41 PM | Bina Joe (Administrator)

    Dear Colleagues,

    At our previous meeting, there was a strong consensus to develop a database with de-identified data on current ranges of salaries and start-up packages  offered to new recruits at Assistant, Associate and Full Prof. levels. While the AAMC data are available, many in our group felt that the chairs having our own database is desirable as a good reference point. There was good discussion on whether this is approriate or not.  It was also shared that this is not a new thought because the Neuroscience chairs group already has such a database.  In the interest of AMSPC growing in  service, I would like to revisit this topic here and hear your thoughts.  If anyone is opposed to this idea, please provide your reasons.  If most of us agree that this is beneficial to us as a group, I would like to move forward with logistics of collecting data anonymously and maintaining a private database accessible exclusively by the AMSPC members.



  • Fri, July 14, 2023 3:25 PM | Karen Gottlieb (Administrator)

    Lou Zou, PhD

    Lee Zou, PhD, has been named the new chair of the Department of Pharmacology and Cancer Biology. He will begin his new role on Feb. 1, 2023. Colin Duckett, PhD, Vice Dean for Basic Science and Professor of Pharmacology and Cancer Biology, has served as interim chair of the department since September 2020. 

    Dr. Zou comes to Duke from Harvard Medical School, where he is a Professor of Pathology at Harvard Medical School and Scientific Co-Director of the Massachusetts General Hospital Cancer Center. He is also the James and Patricia Poitras Endowed Chair of Cancer Research, and a co-leader of the Cancer Cell Biology Program of the Dana Farber/Harvard Cancer Center.  

    Dr. Zou’s research is focused on understanding how DNA damage and DNA replication problems are detected by the ATM and ATR checkpoint pathways in human cells. Work by Dr. Zou and his colleagues has elucidated the mechanisms that activate the ATR checkpoint and the functions of ATR in cancer cells, providing new opportunities for cancer therapy.  

    Dr. Zou obtained his PhD training at the Cold Spring Harbor Laboratory and his postdoctoral training as a Howard Hughes Medical Institute Associate/Postdoctoral Fellow at Baylor College of Medicine and Harvard Medical School.  

    Dr. Zou has earned recognition with numerous honors and awards, including the National Cancer Institute’s Outstanding Investigator Award, the Kraft Prize for Translational Research, and the Breakthrough Award from the Department of Defense. He is a Fellow of the American Association for the Advancement of Science, and he serves on the editorial boards of Molecular Cell, Molecular and Cellular Biology, the Journal of Biological Chemistry, and Cancer Research.  

  • Fri, July 14, 2023 3:23 PM | Karen Gottlieb (Administrator)

    Headshot of Dr. ZachariouVenetia (Vanna) Zachariou, PhD, has accepted the position of chair of pharmacology & experimental therapeutics and physiology & biophysics, effective Dec. 1, 2022, replacing David Farb, PhD, who announced his intention to step down last year, and William Lehman, PhD, who was appointed ad interim chair upon David Atkinson’s announcement last year. The name of the combined department will be chosen after discussions with the faculty, students and other stakeholders.

    Zachariou is professor of neuroscience and pharmacological sciences at the Icahn School of Medicine at Mount Sinai. She studies signal transduction and epigenetic mechanisms of neurological disorders and their treatment using genetic mouse models, genomic assays and brain biochemistry. Current projects investigate transcriptional and epigenetic mechanisms of chronic pain with emphasis on the identification and validation of novel treatments for the management of peripheral neuropathy and other chronic pain conditions. Another line of research in her laboratory investigates the role of G protein signal transduction complexes in drug addiction, opioid analgesia and physical dependence. By understanding intracellular adaptations to peripheral nerve injury and/or prolonged opioid exposure she aims develop novel therapeutics for chronic pain conditions and pain/addiction comorbidities. Her team has identified several intracellular pathways that control the perception and the maintenance of chronic pain states. They also have developed novel interventions in epigenetic pathways that allow transitioning to non-opioid analgesics while preventing the development of physical dependence.

    Zachariou received her BSc in pharmacy from the University of Patras, Greece, and her PhD in pharmacology from the Medical College of Georgia. Following a postdoctoral fellowship in the department of psychiatry at Yale University and a junior faculty position at UT Southwestern Medical Center in Dallas, she established her laboratory at the University of Crete School of Medicine. In 2012, she joined the departments of neuroscience and pharmacological sciences at the Icahn School of Medicine at Mount Sinai in New York as an associate professor (with tenure since 2016), and as full professor (since 2018).

    Zachariou is a member of the editorial boards of Biological Psychiatry, Molecular Pain, Science Signaling, Neurobiology of Pain, section editor for European Journal of Neuroscience, and member of the NIH MCNP study section. She is a Fellow in the American College of Neuropsychopharmacology and Chair elect for the ASPET Neuropharmacology Division.

  • Fri, July 14, 2023 12:24 PM | Karen Gottlieb (Administrator)

    A headshot of Henry Bourne.Henry Bourne (1940-2023)

    Henry Bourne, MD, a long-time researcher at UC San Francisco who chronicled its rise to prominence in the 1970s, has died at the age of 83.  A member of the National Academy of Sciences, Bourne made significant contributions to understanding how cells send their signals to one another. But he is equally remembered for the curiosity and passion that he brought into the laboratory and the campus research community.

    Bourne not only recruited promising students, post-docs, and faculty members to UCSF, particularly when he was department chair, but also gave his fellow scientists the encouragement they needed to persist and even thrive through the difficulties they would inevitably face.  “It was impossible not to get swept up in his infectious enthusiasm,” said Orion Weiner, PhD, a professor in the UCSF Cardiovascular Research Institute who was mentored by Bourne from 1995-2001. “He helped us believe that even very ambitious projects were possible, and with his creativity and insight, they usually were.”

    Bourne arrived at UCSF in 1969 armed with a medical degree, research experience at the National Institutes of Health, and several years of experience as a journalist. With a knack both for exploring the molecular communication between cells and for communicating his findings with colleagues at UCSF and beyond, he quickly earned the admiration of his peers and students. He was welcomed into the faculty of the School of Medicine in 1971.

    “He was fascinated by the ways that the cells in our tissues talk to each other and control each other’s behavior in response to various changes in their environment,” said colleague David Morgan, PhD, vice dean for research at UCSF’s School of Medicine. “But he was bigger than his science and brought an unforgettable spirit to our campus. No matter the topic, he spoke his mind – without filters – about the issues he was passionate about, often in colorful language.”

    Bourne’s research interests began with influential studies on G-protein coupled signaling and, as his career progressed, he moved into studies on cellular pathfinding in the body, or chemotaxis.  Over nearly 40 years as a researcher, Bourne authored more than 150 primary journal articles and 95 book chapters, and earned 17 awards from professional organizations, including induction into the National Academy of Sciences in 1994 and the American Association for the Advancement of Science in 1996. He chaired the UCSF Department of Pharmacology from 1983-1994.

    Bourne was also happy to share his non-scientific interests with his colleagues. After musing about scientists and their relationship with literature, he posted signs around several research buildings inviting people to join him in a book club.  “Over 30 people showed up to read Ulysses together,” recalled Dyche Mullins, PhD, professor in the Department of Cellular and Molecular Pharmacology, who met Bourne when he was considering whether to join the University as a post-doc. “Grad students and post-docs and professors came and attended for weeks, all people who felt like they needed something outside of science to sustain them.”

    After shuttering his lab in 2005 and becoming an emeritus faculty member in 2008, Bourne returned to his first love – writing – and published several books, including a 2009 memoir of his life in science, Ambition and Delight, and a 2017 institutional history of UCSF, Paths to Innovation, which chronicled UCSF’s ascent from a regional medical institution to an internationally recognized leader in biomedical research.  “It’s a book that describes how very important discoveries were made over a period of eight years, in the 1970s, within a diameter of 150 yards, by four different people, three of whom won Nobel prizes,” Bourne said in 2011 upon the book’s publication.  

    Those scientific luminaries – J. Michael Bishop, MD, Harold Varmus, MD, Herbert Boyer, PhD, and Stanley Prusiner, MD – inspired a young Bourne to carry out a lifetime of innovation in the sciences. And Bourne, in turn, spent his later years advocating for change in the education of young scientists.  He penned articles, narrated a video, and dedicated his final book, Follow the Money, to these ideas, which centered on setting up young PhDs for success in academia – primarily by refocusing graduate programs on preparing students for scientific careers.  “He took his role as elder statesman seriously,” said Mullins. “He had seen the way the University operated for the last 30 years and had strong opinions on what worked or didn’t, always meant in the spirit of keeping UCSF an innovative and dynamic and top-notch institution.”

    Bourne, who died on April 15, leaves behind two sons, Michael and Randy, and a daughter, Margaret, as well as five grandchildren.

  • Tue, June 20, 2023 9:23 AM | Karen Gottlieb (Administrator)

    Salvatore J. Enna

    1944 - 2023

    Salvatore J. Enna obituary, 1944-2023, Mission Hills, KS

    December 19, 1944 - June 15, 2023
    Mission Hills, Kansas - Salvatore Joseph Enna, Ph.D. died peacefully in his sleep at his Mission Hills home on June 15, 2023. Sam was born in Kansas City, Missouri on December 19, 1944 to Faye and Veto Enna, the second of five children. As an eight year old, Sam began throwing papers with his father for the Kansas City Star's newspaper routes. As a young adult Sam held multiple odd jobs, among them Elephant Train driver at the Kansas City Zoo, and a member of the night time clean up crew at Leawood Country Club.
    Sam attended Catholic grade schools, Rockhurst High School, and Rockhurst College. Sam was known for his quick wit, and put it to good use when he studied for his Masters and PhD degrees in Pharmacology at the University of Missouri, Kansas City. While still a student, he met Colleen Nestor on a blind date on July 4,1965 at the Starlight Theatre. They married at Visitation Church on July 26, l969.
    Sam's career in pharmacology began with postdoctoral studies at the University of Texas in Dallas, in 1970. With their infant daughter Anne Elizabeth, born in 1972, the family headed to Basle, Switzerland for Sam's studies at Hoffman La Roche Drug Company.
    At a meeting in Strasbourg, France, Sam met Doctor Solomon Snyder and was invited to join his research team at Johns Hopkins University in 1974. Not long after arriving in Baltimore, Matthew Joseph joined our family.
    After completing his postdoctoral studies, Sam accepted an appointment as Assistant Professor at the University of Texas, Houston in 1976. In Houston, Sam and Colleen welcomed their third child, Katharine in 1983. While at UT Houston, Sam won countless teaching awards, and rose to the position of Full Professor.
    Our family moved to Baltimore in 1986, at the invitation of Doctor Solomon Snyder, his Johns Hopkins mentor, who asked Sam to lead the research team at Nova Pharmaceutical.
    In 1993, the family returned to Kansas City. Sam became the Chairman of Pharmacology at the University of Kansas. After nearly thirty years on the faculty, Sam accepted Emeritus status.
    Sam continued his work with Elsevier Publishing Company, editing several journals up to the day of his passing. A special thank you to Lynn Lecount and Jennifer McNichols who worked tirelessly with Sam for years on the Elsevier journals.
    Sam was spirited and generous, a bigger than life personality. He was a loving husband, father, grandfather and friend. He is survived by his wife Colleen, his three children Anne (Tim Hedrick ), Matthew, and Katie (Adam Hobson) and two very special grandchildren Sloan and Madeleine Hobson. Sam's parents, and his brother Frank predeceased him. He is survived by three siblings, John, Nina, and Stephanie.
    For all of his accomplishments, Sam said on numerous occasions that his greatest achievement was his wife and three children. Thanks to Sam's success as a scientist, Colleen and Sam met and dined with scientists around the globe. Sam always stressed to his children the importance of a good education. His children listened. And, they watched this voracious
    reader consume classic literature as well as science.
    The evening before he passed, Sam placed a book that he had edited on the kitchen island. The book is: "Bioactive Lipid Mediators in Cardiopulmonary Pharmacology". A pharmacologist to the end.
    It has been decided that the upcoming International Union of Basic and Clinical Pharmacology meeting in Glasgow, Scotland will be honoring Sam's leadership legacy.
    A memorial service will be held from 2:00 to 4:00 on Friday, June 23, at Muehlebach Funeral Home at 6800 Troost Avenue, Kansas City, Missouri.

  • Thu, February 16, 2023 1:40 PM | Karen Gottlieb (Administrator)

    The updated Pharmacology Knowledge Objectives are now available online! 

    Click the button at the top of the AMSPC website Home page to view and  download the latest PDF file.

  • Thu, February 09, 2023 12:45 PM | Karen Gottlieb (Administrator)

    We hope all members will take 5-10 minutes and update their profiles, update their group preferences, subscribe to forums and upload a headshot photo.   Our new website system, Wild Apricot, is a great because it puts members in complete control of their privacy and communication preferences. 

    Wild Apricot forums require members to opt in by subscribing to each forumSubscribing to forums is optional, but you will want to subscribe to forums if you want timely notifications whenever a new topic or response is added:

  • Mon, August 01, 2022 2:46 PM | Karen Gottlieb (Administrator)

    We’re excited to announce that AMSPC has a brand new look - we've updated our logo and re-imagined our website to better represent our society.  Our website is now live and includes a host of new features, including these member-only benefits:

    • Member Profile area - update your personal info and print a membership card
    • Member Directory - connect & message other AMSPC members
    • Job Board - members can post positions for public access
    • Member Resources - access programs from past years, knowledge objectives and more (coming soon)
    • News / Updates - Sign up to receive instant notifications when news is posted
    • Mobile App - take AMSPC with you wherever you go! 

<< First  < Prev   1   2   3   Next >  Last >> 
AMSPC is a 501(c)3 non-profit organization.

Call or Email Us
Office: 305-661-5581 

Mailing Address:
6524 SW 61st Terrace

Miami, FL 33143

Powered by Wild Apricot Membership Software